PMID- 15610609 OWN - NLM STAT- MEDLINE DCOM- 20050505 LR - 20121115 IS - 1043-0342 (Print) IS - 1043-0342 (Linking) VI - 15 IP - 11 DP - 2004 Nov TI - Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. PG - 1091-100 AB - Malignant gliomas are the most frequent primary brain tumors and have a dismal prognosis due to their infiltrative growth. Gene therapy using viral vectors represents an attractive alternative to conventional cancer therapies. In a previous study, we established lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus (LCMV) glycoproteins (GPs) and demonstrated transduction of human malignant glioma cells in culture. In the current approach, we compared the transduction efficacy of LCMV-GP- and vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped lentiviral vectors for malignant glioma cells and normal brain cells in vitro and in vivo. LCMV-GP pseudotypes transduced almost exclusively astrocytes, whereas VSV-G pseudotypes infected neurons as well as astrocytes. LCMV-GP pseudotypes showed an efficient transduction of solid glioma parts and specific transduction of infiltrating tumor cells. In contrast, VSV-G-pseudotyped lentiviral vectors transduced only a few tumor cells in solid tumor parts and infected mostly normal brain cells in infiltrating tumor areas. In conclusion, lentiviral vectors pseudotyped with LCMV glycoproteins represent an attractive option for gene therapy of malignant glioma. FAU - Miletic, Hrvoje AU - Miletic H AD - Abteilung fur Neuropathologie, Universitat zu Koln, D-50931 Cologne, Germany. h.miletic@uni-koeln.de FAU - Fischer, Yvonne Heidemarie AU - Fischer YH FAU - Neumann, Harald AU - Neumann H FAU - Hans, Volkmar AU - Hans V FAU - Stenzel, Werner AU - Stenzel W FAU - Giroglou, Tsanan AU - Giroglou T FAU - Hermann, Manuel AU - Hermann M FAU - Deckert, Martina AU - Deckert M FAU - Von Laer, Dorothee AU - Von Laer D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Hum Gene Ther JT - Human gene therapy JID - 9008950 RN - 0 (Glycoproteins) RN - 0 (Luminescent Proteins) RN - 0 (fluorescent protein 583) SB - IM MH - Animals MH - Astrocytes/metabolism MH - Brain/embryology/metabolism/pathology MH - Brain Neoplasms/metabolism/*therapy MH - Cell Line MH - Cell Line, Tumor MH - Cells, Cultured MH - Female MH - Fibroblasts/metabolism MH - Genetic Therapy/*methods MH - Genetic Vectors MH - Glioma/*genetics/metabolism/*pathology/*therapy MH - Glycoproteins/*genetics MH - Hippocampus/embryology/metabolism MH - Humans MH - Lentivirus/genetics MH - Luminescent Proteins/pharmacology MH - Lymphocytic choriomeningitis virus/*genetics MH - Microscopy, Fluorescence MH - Neurons/metabolism MH - Rats MH - Rats, Inbred F344 MH - Rats, Wistar EDAT- 2004/12/22 09:00 MHDA- 2005/05/06 09:00 CRDT- 2004/12/22 09:00 PHST- 2004/12/22 09:00 [pubmed] PHST- 2005/05/06 09:00 [medline] PHST- 2004/12/22 09:00 [entrez] AID - 10.1089/hum.2004.15.1091 [doi] PST - ppublish SO - Hum Gene Ther. 2004 Nov;15(11):1091-100. doi: 10.1089/hum.2004.15.1091.